0.00Open0.00Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover131.31%IV-23.67%PremiumOct 18, 2024Expiry Date6.70Intrinsic Value100Multiplier15DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7421Delta0.0428Gamma3.75Leverage Ratio-0.0778Theta-0.0101Rho-2.78Eff Leverage0.0187Vega
Castle Biosciences Stock Discussion
New Data at ASTRO 2024 Shows Castle Biosciences’ DecisionDx®-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma | CSTL Stock News
loading...
loading...
Businesswire· 4 mins ago
No comment yet